The Uromigos Episode 174: Cell-Free DNA as a Biomarker in Bladder Cancer
Amir Goldkorn, MD, discusses translational findings from a phase 2 bladder trial, SWOG data about predicting response to neoadjuvant chemotherapy, and more.
670 Madison Ave.
Manalapan, NJ 07726
Contributors and Partners
Cancer Nursing Today
Urban Health Today
Blood Cancers Today
© 2022 Mashup Media, LLC. All rights reserved.